Radius Health Inc logo

RDUS - Radius Health Inc News Story

$13.52 0.2  1.8%

Last Trade - 6:25pm

Sector
Healthcare
Size
Mid Cap
Market Cap £469.2m
Enterprise Value £536.5m
Revenue £152.5m
Position in Universe 2783rd / 6440

BRIEF-Radius Health Divests Rad 140 Program To Ellipses Pharma

Thu 1st October, 2020 1:46pm
Oct 1 (Reuters) - Radius Health Inc  RDUS.O :
    * RADIUS HEALTH DIVESTS RAD 140 PROGRAM TO ELLIPSES PHARMA
    * RADIUS HEALTH INC - SOLD ITS SECOND ONCOLOGY PIPELINE
ASSET -
RAD 140 - TO ELLIPSES PHARMA LIMITED
    * RADIUS HEALTH INC - ELLIPSES PHARMA WILL BE RESPONSIBLE
FOR
CLINICAL DEVELOPMENT AND COMMERCIALIZATION OF ASSET
    * RADIUS HEALTH INC - RADIUS WILL BE ENTITLED TO RECEIVE
ROYALTIES
ON PROGRAM AS IT ADVANCES WITH ELLIPSES

Source text for Eikon:  ID:nGNX68F9rH 
Further company coverage:  RDUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.